ARCHIVES

Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Chabner : Opportunity To Set Own Agenda Reason For Leaving

October 28, 1994

Perifosine Fails Primary Endpoint, Zentaris CEO Explores Options

April 27, 2012

Group Chairs Seek Role Running NCTN

September 12, 2014

Republican Congress To Shift Priorities, But Cancer May Get New Opportunities

November 18, 1994

Risk of Lymphoma Increases with Hepatitis C Virus Infection

May 25, 2007

Increase In Recommended Levels, OMB’s Forward Funding Create Shortfall In Center’s Budget

April 19, 1985